Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
42.69 USD | +4.45% | -5.01% | +177.57% |
May. 10 | Wedbush Adjusts Vera Therapeutics' PT to $32 From $34, Keeps Neutral Rating | MT |
May. 09 | Vera Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 2.34B |
---|---|---|---|---|---|
Net income 2024 * | -122M | Net income 2025 * | -133M | EV / Sales 2024 * | - |
Net Debt 2024 * | 293M | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-18.3
x | P/E ratio 2025 * |
-17.7
x | Employees | 55 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.63% |
Latest transcript on Vera Therapeutics, Inc.
1 day | +4.45% | ||
1 week | -5.01% | ||
Current month | +8.05% | ||
1 month | -8.25% | ||
3 months | -6.20% | ||
6 months | +219.54% | ||
Current year | +177.57% |
Managers | Title | Age | Since |
---|---|---|---|
Marshall Fordyce
FOU | Founder | 50 | 16-04-30 |
Sean Grant
DFI | Director of Finance/CFO | 39 | 21-07-11 |
Kerry Cooper
CTO | Chief Tech/Sci/R&D Officer | - | 23-05-03 |
Members of the board | Title | Age | Since |
---|---|---|---|
Beth Seidenberg
BRD | Director/Board Member | 67 | 16-05-31 |
Chairman | 63 | 22-05-23 | |
Patrick Enright
BRD | Director/Board Member | 62 | 20-10-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 9 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-15 | 42.69 | +4.45% | 433,843 |
24-05-14 | 40.87 | +0.29% | 373,408 |
24-05-13 | 40.75 | -1.38% | 642,761 |
24-05-10 | 41.32 | -2.39% | 947,081 |
24-05-09 | 42.33 | -5.81% | 644,756 |
Delayed Quote Nasdaq, May 15, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+177.57% | 2.24B | |
+29.77% | 49.18B | |
+1.00% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.68% | 26.09B | |
-22.99% | 18.71B | |
+8.22% | 13.26B | |
+32.41% | 12.32B | |
-1.62% | 11.99B |
- Stock Market
- Equities
- VERA Stock